OBJECTIVE: Obesity and gonadal dysfunction are known major side effects of treatment in adult childhood cancer survivors (CCS). In the general population, obesity has a negative influence on female fertility. We aimed to evaluate whether obesity and serum insulin are associated with decreased ovarian reserve markers in CCS. DESIGN: Retrospective single-center cohort study. METHODS: Data of 191 female survivors of childhood cancer were analyzed. Median follow-up time was 18.8 (2.348.8) years. Outcome measures were serum anti-Müllerian hormone (AMH) and total follicle count (FC). Potential risk factors were: BMI; body composition measures, determined by dual-energy X-ray absorptiometry (total fat percentage, lean body mass, and visceral fat percentage); and fasting insulin. RESULTS: Lower serum AMH was found in obese subjects (β (%) -49, P=0.007) and in subjects with fasting insulin in the highest tertile (β (%) -43, P=0.039). Total fat percentage tends to be associated with serum AMH (β (%) -2.1, P=0.06). Survivors in the highest tertile of insulin had significantly lower FC than survivors in the lowest tertile (β -6.3, P=0.013). BMI and other measures of body composition were not associated with FC. Correlation between serum AMH and antral follicle count (AFC) was ρ=0.32 (P=0.08). CONCLUSIONS: Obesity and insulin resistance are associated with gonadal damage, as reflected by decreased AMH and reduced FC in adult survivors of childhood cancer. In contrast to its highly predictive value for AFC in the healthy female population, serum AMH does not seem to correlate as well with AFC in CCS.
OBJECTIVE:Obesity and gonadal dysfunction are known major side effects of treatment in adult childhood cancer survivors (CCS). In the general population, obesity has a negative influence on female fertility. We aimed to evaluate whether obesity and serum insulin are associated with decreased ovarian reserve markers in CCS. DESIGN: Retrospective single-center cohort study. METHODS: Data of 191 female survivors of childhood cancer were analyzed. Median follow-up time was 18.8 (2.348.8) years. Outcome measures were serum anti-Müllerian hormone (AMH) and total follicle count (FC). Potential risk factors were: BMI; body composition measures, determined by dual-energy X-ray absorptiometry (total fat percentage, lean body mass, and visceral fat percentage); and fasting insulin. RESULTS: Lower serum AMH was found in obese subjects (β (%) -49, P=0.007) and in subjects with fasting insulin in the highest tertile (β (%) -43, P=0.039). Total fat percentage tends to be associated with serum AMH (β (%) -2.1, P=0.06). Survivors in the highest tertile of insulin had significantly lower FC than survivors in the lowest tertile (β -6.3, P=0.013). BMI and other measures of body composition were not associated with FC. Correlation between serum AMH and antral follicle count (AFC) was ρ=0.32 (P=0.08). CONCLUSIONS:Obesity and insulin resistance are associated with gonadal damage, as reflected by decreased AMH and reduced FC in adult survivors of childhood cancer. In contrast to its highly predictive value for AFC in the healthy female population, serum AMH does not seem to correlate as well with AFC in CCS.
Authors: Julie S Rios; Eleni A Greenwood; Mary Ellen G Pavone; Marcelle I Cedars; Richard S Legro; Michael P Diamond; Nanette Santoro; Fangbai Sun; Randal D Robinson; Gregory Christman; Heping Zhang; Heather G Huddleston Journal: J Clin Endocrinol Metab Date: 2020-01-01 Impact factor: 5.958
Authors: Anita Hokken-Koelega; Aart-Jan van der Lely; Berthold Hauffa; Gabriele Häusler; Gudmundur Johannsson; Mohamad Maghnie; Jesús Argente; Jean DeSchepper; Helena Gleeson; John W Gregory; Charlotte Höybye; Fahrettin Keleştimur; Anton Luger; Hermann L Müller; Sebastian Neggers; Vera Popovic-Brkic; Eleonora Porcu; Lars Sävendahl; Stephen Shalet; Bessie Spiliotis; Maithé Tauber Journal: Endocr Connect Date: 2016-11-01 Impact factor: 3.335
Authors: Sandra M Dumanski; Todd J Anderson; Kara A Nerenberg; Jayna Holroyd-Leduc; Jennifer MacRae; Satish R Raj; Amy Metcalfe; Sharanya Ramesh; Cindy Z Kalenga; Darlene Sola; Milada Pajevic; Sofia B Ahmed Journal: Physiol Rep Date: 2022-01
Authors: Malgorzata E Skaznik-Wikiel; Delaney C Swindle; Amanda A Allshouse; Alex J Polotsky; James L McManaman Journal: Biol Reprod Date: 2016-03-30 Impact factor: 4.285
Authors: Vincent Pluimakers; Marta Fiocco; Jenneke van Atteveld; Monique Hobbelink; Dorine Bresters; Eline Van Dulmen-den Broeder; Margriet Van der Heiden-van der Loo; Geert O Janssens; Leontien Kremer; Jacqueline Loonen; Marloes Louwerens; Helena Van der Pal; Cécile Ronckers; Hanneke Van Santen; Birgitta Versluys; Andrica De Vries; Marry Van den Heuvel-Eibrink; Sebastian Neggers Journal: JMIR Res Protoc Date: 2021-01-27
Authors: Renée M G Verdiesen; N Charlotte Onland-Moret; Carla H van Gils; Rebecca K Stellato; Annemieke M W Spijkerman; H Susan J Picavet; Frank J M Broekmans; W M Monique Verschuren; Yvonne T van der Schouw Journal: Diabetologia Date: 2020-10-13 Impact factor: 10.122